INTRODUCTION
Chondrocytes are differentiated from mesenchymal cells during embryo development (1, 2) . The phenotypes of differentiated chondrocytes in articular cartilage are characterized by the synthesis and maintenance of cartilage-specific extracellular matrix molecules, including type II collagen and proteoglycans such as aggrecan. However, the differentiated phenotype is unstable both in vivo and in vitro, and thus lost by a process designated'dedifferentiation' upon exposure of cells to interleukin-1β (3, 4) , nitric oxide (NO 1 ) (5) or retinoic acid (6, 7) and during serial monolayer culture (8, 9) . NO mediates the regulation of chondrocyte phenotype and survival by inducing dedifferentiation and apoptosis (5, 10, 11) .We previously showed that direct production of NO by treatment of primary culture articular chondrocytes with a NO donor, sodium nitroprusside (SNP), led to apoptosis, dedifferentiation and cyclooxygenase (COX-2) expression via a complex protein kinase signaling cascade involving mitogen-activated protein (MAP) kinase and protein kinase C (PKC) (12) (13) (14) (15) . For example, NO-induced activation of extracellular signal-regulated protein kinase (ERK) promotes dedifferentiation, COX-2 expression and inhibition of apoptosis, whereas NO-induced p38 kinase activation triggers apoptosis, COX-2 expression and maintains differentiated phenotypes (12, 15) .NO additionally inhibits protein kinase C (PKC) α and ζ activities (13) . PKCα activity is inhibited due to blockage of expression independent of MAP kinase signaling, whereas PKCζ activity is suppressed as a result of p38 kinase activation that follows proteolytic cleavage by caspase-3. Inhibition of PKCα and ζ is necessary for NO-induced dedifferentiation and nuclear factor (NF)-κB activation (15) . Activated NF-κB has dual functions, specifically, induction of COX-2 expression and subsequent PGE2 production, and apoptosis by stimulating p53 transcription. A previous study by our group also reveals that p38 kinase stimulates NO-induced apoptosis via p53 accumulation as a result of stabilization due to serine-15 phosphorylation (14) .
The actin cytoskeletal architecture is believed to be an important modulator of chondrocyte phenotype.
Dedifferentiation of chondrocytes by retinoic acid or serial monolayer culture is accompanied by significant by guest on http://www.jbc.org/ Downloaded from changes in actin cytoskeletal architecture. Disruption of the actin cytoskeleton by dihydrocytochalasin B promotes redifferentiation of chondrocytes (16, 17) . The actin cytoskeleton additionally mediates changes in articular chondrocyte phenotype induced by bone morphogenetic protein (18) or NO (19) . Furthermore, disruption of the actin cytoskeleton by cytochalasin D (CD) triggers chondrogenesis in limb mesenchymal cells (20) (21) (22) (23) , indicating a function in the regulation ofchondrogenic differentiation of mesenchymal cells and maintenance of differentiated chondrocyte phenotype. However, to date, the molecular mechanism underlying the regulatio n of chondrocyte phenotype by actin cytoskeletal architecture has yet to be fully elucidated.
In addition to regulating chondrocyte phenotype, the actin cytoskeleton modulates apoptosis either positively or negatively in a variety of cell types, depending on the experimental system (24) (25) (26) . For instance, disruption of the actin cytoskeleton causes apoptosis of capillary endothelial cells (27) , airway epithelial cells (28) , T cells (29), megakaryoblastic leukemia cells (30) and dentate granule cells (31), but inhibits apoptosis in B lymphocytes (32) and lymphoma cells (33). However, it is currently unknown whether actin cytoskeleton also regulates apoptosis of articular chondrocytes.
In view of the evident significance of the actin cytoskeletal architecture in the physiology of chondrocytes and cartilage, we initially investigated its role in NO-induced dedifferentiation, apoptosis and inflammatory responses, such as cyclooxygenase (COX)-2 and prostaglandin E 2 (PGE 2 ) production in primary culture rabbit articular chondrocytes. We additionally characterized the molecular mechanism of regulation of chondrocyte function by the actin cytoskeleton, focusing on the roles of MAP kinase and PKC. Here we report that disruption of the actin cytoskeleton by CD results in the inhibition of NO-induced dedifferentiation, apoptosis, COX-2 expression and PGE 2 production in articular chondrocytes via modulation of MAP kinase activation and inhibition of PKCα and ζ signaling.
by guest on http://www.jbc.org/ Downloaded from organization in primary culture articular chondrocytes or cartilage explants, which were either left untreated or treated with various pharmacological reagents. Briefly, primary culture chondrocytes were fixed with 3.5% paraformaldehyde in PBS for 10 min at room temperature. Cells were permeabilized and blocked in PBS containing 0.1% Triton X-100 and 5% fetal calf serum for 30 min. Fixed cells were washed with PBS and incubated for 1 h with rhodamine-conjugated phalloidin, re-washed, and then observed under a standard fluorescence microscope (38).
Determination of cell death -NO induces apoptosis in chondrocytes, as previously demonstrated by
DNA fragmentation and terminal deoxynucleotidyl transfer-mediated nick end labeling (TUNEL) assays (12) .
Apoptotic cell death in cartilage explants was determined by TUNEL method using an assay kit (Roche Molecular Biochemicals, Indianapolis, IL). Apoptotic cells were additionally quantified using approximately 1 ×
10
4 cells on a FACSort flow cytometer with the Cellquest analysis program (Becton Dickinson, Mountain View, CA), as described previously (12) .
Assay of caspase-3 activity -Caspase-3 activation in SNP-treated chondrocyteswas determined by measuring the absorbance of a cleaved synthetic substrate of caspase-3, Ac-Asp-Glu-Val-Asp-chromophore pnitroaniline (12) . Briefly, chondrocytes were lysed on ice for 10 min in cell lysis buffer provided in the 
RESULTS

Disruption of the actin cytoskeleton inhibits NO-induced apoptosis of articular chondrocytes -We have
previously shown that direct production of NO by SNP in primary culture articular chondrocytes results in apoptosis and dedifferentiation (12) (13) (14) (15) . Prior to determining the role of the actin cytoskeleton in NO-induced apoptosis, we examined the organization of actin filaments in articular chondrocytes. The actin cytoskeleton in primary culture chondrocytes at passage 0 comprised a stress fiber-like structure or thick struts of actin fiber extended across the length of the chondrocytes (Fig. 1A) . NO induced a typical peripheral distribution of actin filaments that is consistent with their mechanical supporting function for shrinking apoptotic cells. Treatment with CD led to collapse of the filamentous actin structure to amorphous clots of depolymerized protein and a blocked NO-induced apoptosis (Fig. 3D) , the above results indicate that inhibition of these activities by disruption of the actin cytoskeleton is responsible for the suppression ofcell death.
We previously (13) demonstrated that protein levels and activities of PKCα and ζ, signaling molecules upstream of NF-κB activation and p53 accumulation, decrease upon NO production. Moreover, these events are by guest on September 1, 2017
http://www.jbc.org/ Downloaded from necessary for apoptosis and dedifferentiation of chondrocytes. We additionally showed that PKCζ activity is inhibited as a result of p38 kinase activation, whereas suppression of PKCα activity is independent of MAP kinase signaling (12, 13) . Accordingly, we examined whether disruption of the actin cytoskeleton blocks NOinduced apoptosis via the modulation of MAP kinase and PKCα and ζ signaling. As depicted in Fig , potentiated apoptosis, whereas 20 µM SB203580 (a p38 kinase inhibitor) blocked apoptosis (Fig. 3D) .
Therefore, suppression of p38 kinase activation appears to be responsible for apoptosis inhibition upon actin cytoskeleton disruption.
We recently observed that NO production in articular chondrocytes inhibits cell survival signaling, including phosphatidylinositol 3-kinase (PI3-kinase) and Akt, a process that is necessary for NO-induced apoptosis (40). Based on this finding, we investigated whether CD treatment modulates the cell survival signal to block NO-induced apoptosis. As shown in dedifferentiation were similar to those of IGF-1, we investigated whether IGF-1 exerts its effects by modulating actin filaments. Similar to the effects of CD, IGF-1 treatment caused disruption of stress fiber and formation of amorphous clots of depolymerized actin (Fig. 7A) . The effects of IGF-1on actin cytoskeleton were abolished by the treatment of jasplakinolide, whichcauses formation of more stress fiber and aggregations of actin filaments (Fig. 7A) . Jasplakinolide abolished IGF-1-induced enhancement of type II collagen expression (Fig. 7B) and completely blocked the inhibitory effects of IGF-1 on NO-induced apoptosis (Fig. 7C) . Therefore, the above results suggest that the stimulatory effect and the inhibitor effect of IGF-1 on type II collagen expression and on NO-induced apoptosis, respectively, is due to its ability to disrupt the actin cytoskeleton.
Actin cytoskeleton regulates COX-2 expression and PGE 2 production in art icular chondrocytes -The
finding that NO induces COX-2 expression and PGE 2 production in articular chondrocytes (15)prompted an investigation into the role of the actin cytoskeleton in the regulation of COX-2 expression and PGE 2 production.
As expected, NO production caused a significant increase in COX-2 expression and PGE 2 production, which was blocked by the disruption of actin filaments with CD treatment (Figs. 8A upper panel and 8B) . In contrast, stabilization of actin filaments by jasplakinolide caused COX-2 expression in the absence of NO production and even enhanced NO-induced COX-2 expression (Fig. 8A) , indicating a critical role of actin dynamics in NOinduced COX-2 expression and PGE 2 production. We focused on the roles of MAP kinase subtypes in regulation by the actin cytoskeleton, since ERK-1/-2 and p38 kinase modulate COX-2 expression and subsequent PGE2 production (41-44).NO triggered the activation of ERK-1/-2 and p38 kinase, as establishedby
Western blot analyses and an in vitro kinase assay, respectively (Fig. 8C, upper panel) . PD98059, an inhibitor of ERK-1/-2,partially blocked COX-2 expression (Fig. 8B , middle panel) but completely suppressed PGE 2 production (Fig. 8C) , probably by inhibiting its activity. In contrast, the p38 kinase inhibitor, SB203580, completely abolished both COX-2 expression (Fig. 8B , lower panel) and PGE 2 production (Fig. 8C) . The results indicate that activities of ERK-1/-2 and p38 kinase are required for COX-2 expression and subsequent PGE 2 production induced by NO. Since disruption of the actin cytoskeleton blocks NO-induced activation of p38
kinase, but not ERK-1/-2, the above results imply that the inhibition of p38 kinase activation by CD is responsible for the blockage of COX-2 expression and subsequent PGE2 production.
Actin cytoskeleton regulates NO-induced apoptosis, dedifferentiation and COX-2 expression in articular
chondrocytes during cartilage explants culture -Since the response of chondrocytes in monolayer culture may differ from that in a three-dimensional natural matrix, we examined whether the cytoskeletal architecture in chondrocytes regulates NO-induced apoptosis, dedifferentiation and COX-2 expression during cartilage explants culture. F-actin was strongly stained in the peripheral region of chondrocytes in cartilage explants. SNP treatment resulted in strong homogenous staining of F-actin, and CD reversed the effects of NO production (Fig.   9A ). Analogous to the data obtained with chondrocytes cultured on plastic, NO induced an increase in TUNELpositive chondrocytes and reduced Alcian blue staining. The effects of NO were blocked upon treatment of cartilage explants with CD (Fig. 9A) . CD additionally inhibited NO-induced COX-2 expression in chondrocytes during cartilage explants culture (Fig. 9B) . Thus, disruption of the actin cytoskeletal architecture blocks NOinduced apoptosis, dedifferentiation and COX-2 expression in chondrocytes cultured either on plastic or a threedimensional natural matrix.
DISCUSSION
CD is a fungal metabolite that inhibits actin polymerization and disrupts existing actin filaments by binding to high-affinity sites located at their polymerization ends. Jasplakinolide, which is a macrocyclic peptide isolated from the marine sponge Jaspis johnstoni, induces actin polymerization and stabilizes actin in a polymeric state. Using CD and jasplakinolide, we show that the actin cytoskeletal architecture is a critical To date, the mechanisms underlying the regulation of signaling molecules, including PI3-kinase, Akt, p38 kinase and PKC, by the actin cytoskeleton are not clearly understood. Disruption of the actin cytoskeleton did not affect ERK activation, but blocked activation of p38 kinase and inhibition of PKCα and ζ. Since PKCζ activity is blocked as a result of p38 kinase activation (13), it is likely that blockage of PKCζ inhibition by CD is due to suppression of the upstream signaling molecule, p38 kinase. The signaling molecule mediating NOinduced inhibition of PKCα that is independent of MAP kinase signaling remains to be identified. We did not attempt to determine the target molecules regulated by CD to modulate PKCα in this study. However, our results indicate that p38 kinase-dependent and -independent PKCζ and α regulate NF-κB activation that leads to the accumulation of p53 and activation of caspase-3, and consequently chondrocyte apoptosis (15) . Therefore, inhibition of NO-induced apoptosis by disruption of the actin cytoskeleton is consistent with the suppression of actionare not elucidated in this study. Actin is a known substrate of caspases (46, 47) , and is cleaved in a caspase-3-dependent manner during NO-induced apoptosis (data not shown). It is suggested that actin depolymerization is linked to DNA degradation (46) and either inhibits (27-31) or promotes apoptosis (32, 33), depending on the cell type.
The observation that the actin cytoskeleton regulates chondrocyte phenotype is consistent with earlier reports. For example, chondrocytes lose their differentiated phenotype during in vitro culture, a process that is blocked by disruption of the actin cytoskeleton (16, 17, 48) . The re-expression of differentiated chondrocyte phenotype uponactin cytoskeleton disruption is independent of cell shape change, but mediated by reorganization of the actin cytoskeletal architecture (17) . However, the molecular mechanism mediating the maintenance of differentiated phenotype is yet to be elucidated. Consequently, we investigated the role of the actin cytoskeleton in NO-induced dedifferentiation. Our data show that disruption of the actin structure induces suppression of dedifferentiation by blocking NO-induced inhibition of PKCα and ζ. This conclusion is consistent with our previous observation that ectopic expression of PKCα and ζ blocks NO-induced dedifferentiation (13) . Although inhibition of p38 kinase activation by CD is consistent with blockage of the downstream signaling molecule PKCζ, it is not critical for the inhibition of NO-induced dedifferentiation. This conclusion is based on the finding that inhibition of NO-induced p38 kinase acts as a signal to potentiate NOinduced dedifferentiation (12) . We therefore speculate that blockage of the inhibition of PKCα and ζ, rather than the inhibition of p38 kinase activation, as a result of actin cytoskeleton disruption is responsible for the Our current investigation clearly shows that actin cytoskeleton disruption blocks COX-2 induction and PGE 2 production induced by NO. We demonstrate that actin cytoskeleton disruption abrogates COX-2 induction and PGE 2 production, due to its ability to block activation of p38 kinase. Our data are consistent with reports by other groups that p38 kinase regulates COX-2 expression and subsequent PGE 2 production in various cell types (40-44). In agreement with our results in chondrocytes, disruption of microtubules led to an increase in COX-2 expression and PGE 2 release mediated by p38 kinase in human mammary epithelial cells (49) , and actin cytoskeleton disruption triggered COX-2 expression and PGE 2 release in human umbilical endothelial cells (50) .
Although PGE 2 is known to regulate differentiation of chondrocytes (51, 52) , have previously shown that indomethacin inhibits NO-induced dedifferentiation and apoptosis independent of the expression of COX-2 and PGE2 production. Furthermore, specific inhibition of COX-2 with NS398 that completely blocked NO-induced PGE 2 production, but did not affect apoptosis and accumulation of sulfated proteoglycans. In addition, treatment of chondrocytes with various concentrations of PGE 2 in the absence or presence of SNP did not affect cell viability, accumulation of sulfated proteoglycan, and or type II col lagen expression (53) . Therefore, it is likely that COX-2 expression and PGE2 production is not a cause of NO-induced dedifferentiation and apoptosis. 
